Since epilepsy research currently aims to understand the fundamental role of inflammation in seizure development, we studied the CD40L–CD40 activation in experimental seizures induced by pentylenetetrazol (PTZ) or pilocarpine in wild type (WT) and CD40 receptor-deficient adult mice (CD40KO) using animal models for translational clinical seizures. This evidence concerns the gene CD40 and epilepsy.